Patient Pathfinder: Clinical Trials
Clinical Trials for Bladder Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 278 active Bladder Cancer trials
A University-Community Partnership to Reduce Exposure to Disinfection Byproducts In Appalachia
Study Type: Interventional
Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer
Study Type: Interventional Phase 2
A Study to Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer
Study Type: Interventional Phase 1
Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder
Study Type: Interventional Phase 1
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
Study Type: Interventional Phase 1
Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors
Study Type: Interventional
BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
Study Type: Interventional
Intracorporeal vs Extracorporeal Urinary Diversion After Robot Assisted Radical Cystectomy
Study Type: Interventional
There are 278 active Bladder Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now